Topic archive Updated just now Live coverage

mRNA flu vaccine approval

Selected earlier One News Page coverage related to mRNA flu vaccine approval.

US 1 story 4 sources 4 references

There is no live coverage for this topic at present. Earlier published reports remain available below.

Coverage timeline

Earlier reports

Selected reports from this topic’s recent coverage history.

Earlier report Filed 7 Aug, 08:41 UTC FDA Approves Moderna's mRNA Flu Vaccine The U.S. Food and Drug Administration has approved Moderna's mRNA-based seasonal flu vaccine, the first of its kind, for older adults. The vaccine, named mFlusiva, uses the same mRNA platform as Moderna's Covid-19 shot and will be available for the upcoming flu season. The agency had initially declined to review the application before reversing course following public pressure. US · 4 sources